GeoVax Labs Inc. (NASDAQ:GOVX – Get Free Report) was the target of a large decline in short interest in the month of January. GeoVax Labs (NASDAQ:GOVX – Get Free Report) last posted its quarterly earnings data on Thursday, November 13th. GeoVax Labs had a negative net margin of 403.88% and a negative return on equity of 489.67%. GeoVax Labs Company Profile(Get Free Report)GeoVax Labs, Inc is a clinical-stage biotechnology company focused on the development of novel vaccines and immunotherapies against infectious diseases. See AlsoReceive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.